The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Implementing the bispecific outpatient safe step-up (BOSS) program for elranatamab in ambulatory treatment of multiple myeloma.
 
Diana Cirstea
Consulting or Advisory Role - Sanofi
 
E. Bridget Kim
No Relationships to Disclose
 
Sarah O'Neill
No Relationships to Disclose
 
Kacthary Sanclemente
No Relationships to Disclose
 
Matthew Lei
Consulting or Advisory Role - AstraZeneca; BTG; Genmab; Gentech
 
Alexis Barselau
No Relationships to Disclose
 
Rajib Shome
No Relationships to Disclose
 
Advait Joshi
No Relationships to Disclose
 
Andrew Yee
Consulting or Advisory Role - Abbvie/Genentech; Adaptive Biotechnologies; Amgen; Bristol-Myers Squibb; Celgene; GlaxoSmithKline; Johnson & Johnson/Janssen; Karyopharm Therapeutics; Karyopharm Therapeutics; Oncopeptides; Pfizer; Prothena; Regeneron; Sanofi; Sebia
Research Funding - Amgen (Inst); Bristol-Myers Squibb (Inst); C4 Therapeutics (Inst); Celgene (Inst); GlaxoSmithKline (Inst); Johnson & Johnson/Janssen (Inst); K36 Therapeutics (Inst); Sanofi (Inst); Takeda (Inst)
 
Andrew Branagan
No Relationships to Disclose
 
Benjamin Puliafito
No Relationships to Disclose
 
Noopur Raje
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; Caribou Biosciences; Celgene; Immuneel Therapeutics; Janssen Oncology; Merck; Pfizer; Takeda
Research Funding - Bluebird Bio (Inst); Pfizer (Inst)